Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 6 of 6 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bosentan | 1件: Bosentan Bosentan | 2件: Bosentan
Bosentan
,Bosentan 💬 | 2件: EDNRA EDNRA,EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in c ... | 10件: 41 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬1. Bosentan
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | DEXMEDETOMIDINE | 1件: Dexmedetomidine Dexmedetomidine | 1件: Dexmedetomidine
Dexmedetomidine
💬2. DEXMEDETOMIDINE
| 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬2. DEXMEDETOMIDINE
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Liothyronine | 1件: Liothyronine Liothyronine | 1件: Liothyronine
Liothyronine
💬3. Liothyronine
| 2件: THRA THRA,THRB 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 3件: 13 13, 210, 212 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Liothyronine I 131 | 2件: Liothyronine Liothyronine,Liothyronine I-131 | 1件: Liothyronine
Liothyronine
💬4. Liothyronine I 131
| 2件: THRA THRA,THRB 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | 2件: 210 210, 212 💬
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Sildenafil | 1件: Sildenafil Sildenafil | 1件: Sildenafil
Sildenafil
💬5. Sildenafil
| 1件: PDE5A PDE5A 💬5. Sildenafil
| 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬5. Sildenafil
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Vitamin C | 1件: Ascorbic acid Ascorbic acid | 1件: Ascorbic acid
Ascorbic acid
💬6. Vitamin C
| - | - | 6件: 10 10, 192, 206, 210, 211, 212 💬
|